Old Web
English
Sign In
Acemap
>
Paper
>
CPX 351 As First Line Treatment in Higher Risk MDS. a Phase II Trial By the GFM
CPX 351 As First Line Treatment in Higher Risk MDS. a Phase II Trial By the GFM
2021
Pierre Peterlin
Pascal Turlure
Patrice Chevallier
Marie-Pierre Gourin
Pierre-Yves Dumas
Sylvain Thepot
Anna Berceanu
Sophie Park
Thomas Cluzeau
Jose Miguel Torregrosa Diaz
Louis Devron
Sylvie Chevret
Marie C. Béné
Yannick Le Bris
Rosa Sapena
Fatiha Chermat
Sophie Dimicoli-Salazar
Pierre Fenaux
Keywords:
Oncology
Phase (matter)
Internal medicine
Materials science
first line treatment
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]